Robert Leman to Female
This is a "connection" page, showing publications Robert Leman has written about Female.
Connection Strength
0.130
-
Significant complications can occur with ischemic heart disease and tilt table testing. Pacing Clin Electrophysiol. 1999 Apr; 22(4 Pt 1):675-7.
Score: 0.009
-
The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2016 Aug; 39(8):863-9.
Score: 0.007
-
The impact of device recall on patients and family members of patients with automatic implantable cardioverter defibrillators. Heart Lung. 1994 Jul-Aug; 23(4):317-22.
Score: 0.006
-
The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2014 Jun; 25(6):624-30.
Score: 0.006
-
Cerebral monitoring during implantation of automatic internal cardiac defibrillators. South Med J. 1993 May; 86(5):533-6.
Score: 0.006
-
Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol. 2013 Apr 15; 111(8):1165-8.
Score: 0.006
-
A prospective, randomized comparison of the acute hemodynamic effects of biventricular and left ventricular pacing with cardiac resynchronization therapy. Heart Rhythm. 2011 May; 8(5):685-91.
Score: 0.005
-
Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
Score: 0.005
-
Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract. Heart Rhythm. 2010 Nov; 7(11):1561-6.
Score: 0.005
-
The potential utility of sensor-driven pacing in DDD pacemakers. Am Heart J. 1989 Nov; 118(5 Pt 1):919-23.
Score: 0.005
-
Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing. Am J Cardiol. 2009 Nov 01; 104(9):1256-8.
Score: 0.004
-
Acute hemodynamic effects of atrial pacing with cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2009 Aug; 20(8):894-900.
Score: 0.004
-
Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):383-90.
Score: 0.004
-
The effect of dofetilide on ventricular defibrillation thresholds. Pacing Clin Electrophysiol. 2009 Jan; 32(1):24-8.
Score: 0.004
-
Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
Score: 0.004
-
Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm. 2008 Mar; 5(3):394-9.
Score: 0.004
-
Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular dysfunction: a change in the measuring stick. J Am Coll Cardiol. 1987 Nov; 10(5):991-7.
Score: 0.004
-
A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2007 May; 18(5):490-6.
Score: 0.004
-
Resolution of congestive cardiomyopathy caused by supraventricular tachycardia using amiodarone. Am Heart J. 1986 Sep; 112(3):622-4.
Score: 0.004
-
Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial. J Natl Med Assoc. 2006 Mar; 98(3):330-9.
Score: 0.004
-
Radionuclide evaluation of dual chamber pacing: comparison between variable AV intervals and ventricular pacing. Pacing Clin Electrophysiol. 1985 May; 8(3 Pt 1):408-14.
Score: 0.003
-
Relation of initial resting ventricular rate to the ability to achieve and maintain normal sinus rhythm in patients with atrial fibrillation. Am J Cardiol. 2005 Mar 01; 95(5):597-602.
Score: 0.003
-
Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial). Am J Cardiol. 2005 Mar 01; 95(5):665-6.
Score: 0.003
-
Efficacy of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated exponential shock waveform at variable initial shock energies. Am J Cardiol. 2004 Dec 15; 94(12):1572-4.
Score: 0.003
-
Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol. 2003 Feb; 14(2):144-9.
Score: 0.003
-
Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. Pacing Clin Electrophysiol. 2003 Jan; 26(1P2):483-6.
Score: 0.003
-
Heart disease and pregnancy. South Med J. 1981 Aug; 74(8):944-6.
Score: 0.003
-
Driving with an internal defibrillator: legal, ethical, and quality-of-life issues. J Cardiovasc Nurs. 1997 Jan; 11(2):58-67.
Score: 0.002
-
Driving safety among patients with automatic implantable cardioverter defibrillators. JAMA. 1993 Oct 06; 270(13):1587-8.
Score: 0.001
-
Chronotropic incompetence: a common and progressive finding in pacemaker patients. Am Heart J. 1992 May; 123(5):1216-9.
Score: 0.001
-
Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial. Am J Cardiol. 1987 Dec 14; 60(17):29I-35I.
Score: 0.001
-
Limitations of the long-term clinical application of rate hysteresis. Pacing Clin Electrophysiol. 1987 Mar; 10(2):302-4.
Score: 0.001
-
An argument for pacemaker reuse: pacemaker mortality in 169 patients over ten years. Pacing Clin Electrophysiol. 1986 Nov; 9(6 Pt 2):1295-8.
Score: 0.001
-
Use of combined calcium channel blockers for therapy of refractory angina pectoris. J S C Med Assoc. 1986 Feb; 82(2):65-8.
Score: 0.001
-
Steroid treatment of the painful pacemaker pocket. Pacing Clin Electrophysiol. 1984 Jan; 7(1):71-3.
Score: 0.001